For investors seeking a solid return few strategies beat the classic ‘buy the dip’ approach. The idea is simple: spot a stock ...

Myriad Genetics (MYGN) stock was upgraded to Overweight by Piper Sandler, citing a balanced risk-reward set up for its beaten ...

Atlas Energy Solutions launched at Piper Sandler with an Overweight rating, attracted to multiple growth avenues, ...

Ulta Beauty (NASDAQ:ULTA – Free Report) had its target price decreased by Piper Sandler from $425.00 to $364.00 in a research ...

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...

Piper Sandler expects the bill to pass along party lines. "Once it makes it over to the Senate, at least eight Democrats will ...

Learn more about whether Franklin Resources, Inc. or Piper Sandler Companies is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Arizona State Retirement System lifted its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 0.8% in the ...

Artificial intelligence took the tech world by storm at the end of 2022, with the introduction of ChatGPT and generative AI. The past few years ...

Fintel reports that on March 12, 2025, Piper Sandler upgraded their outlook for Myriad Genetics (NasdaqGS:MYGN) from Neutral ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a ...

Short sellers have been increasing their bets, with short interest now accounting for 6.1% of the stock's available float.